✦ LIBER ✦

Once-Weekly Risedronate in Men With Osteoporosis: Results of a 2-Year, Placebo-Controlled, Double-Blind, Multicenter Study

✍ Scribed by Steven Boonen; Eric S Orwoll; Dietrich Wenderoth; Karen J Stoner; Rachelle Eusebio; Pierre D Delmas

Book ID: 111485671
Publisher: American Society for Bone and Mineral Research
Year: 2009
Tongue: English
Weight: 479 KB
Volume: 24
Category: Article
ISSN: 0884-0431
DOI: 10.1359/jbmr.081214

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A three-year double-blind placebo-contro

A three-year double-blind placebo-controlled study of risedronate in postmenopausal osteoporosis

✍ A N Taquet; B. Clemmensen; B. Zegels; P. Ravin; C. Christiansen; I. Roumagnac; J 📂 Article 📅 1996 🏛 Springer-Verlag 🌐 English ⚖ 152 KB

Treatment With Once-Weekly Alendronate 7

Treatment With Once-Weekly Alendronate 70 mg Compared With Once-Weekly Risedronate 35 mg in Women With Postmenopausal Osteoporosis: A Randomized Double-Blind Study

✍ Clifford J Rosen; Marc C Hochberg; Sydney L Bonnick; Michael McClung; Paul Mille 📂 Article 📅 2004 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 243 KB

Once-weekly administration of 50 mg etan

Once-weekly administration of 50 mg etanercept in patients with active rheumatoid arthritis: Results of a multicenter, randomized, double-blind, placebo-controlled trial

✍ Edward C. Keystone; Michael H. Schiff; Joel M. Kremer; Shelly Kafka; Michael Lov 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 2 views

## Abstract ## Objective To evaluate the safety, efficacy, and pharmacokinetics of 50 mg etanercept administered subcutaneously once weekly in adult patients with active rheumatoid arthritis (RA). ## Methods Four hundred twenty RA patients were randomized to receive, in a blinded manner, the stu

Evidence for safety and efficacy of rise

Evidence for safety and efficacy of risedronate in men with osteoporosis over 4 years of treatment: Results from the 2-year, open-label, extension study of a 2-year, randomized, double-blind, placebo-controlled study

✍ Steven Boonen; Roman S. Lorenc; Dietrich Wenderoth; Karen J. Stoner; Rachelle Eu 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 235 KB

Pulsed estrogen therapy in prevention of

Pulsed estrogen therapy in prevention of postmenopausal osteoporosis. A 2-year randomized, double blind, placebo-controlled study

✍ ThereseF. Nielsen; Pernille Ravn; YuZ. Bagger; Lise Warming; Claus Christiansen 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 290 KB

Sustained efficacy of risedronate in men

Sustained efficacy of risedronate in men with primary and secondary osteoporosis: results of a 2-year study

✍ Johann D. Ringe; Parvis Farahmand; Herbert Faber; Alfred Dorst 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 300 KB